Key Insights
The European diabetic care devices market, valued at €8.03 billion in 2025, is projected to experience robust growth, driven by rising prevalence of diabetes, an aging population, and increasing awareness about effective diabetes management. A Compound Annual Growth Rate (CAGR) of 6.18% from 2025 to 2033 indicates a significant market expansion. Key growth drivers include technological advancements in continuous glucose monitoring (CGM) systems, the development of more user-friendly insulin delivery devices like insulin pumps and pens, and rising demand for self-monitoring blood glucose (SMBG) devices. The market is segmented into monitoring devices (SMBG, CGM), and management devices (insulin pumps, infusion sets, insulin syringes, cartridges, disposable pens, jet injectors). While the SMBG segment currently holds a larger market share, the CGM segment is expected to witness faster growth due to its improved accuracy and convenience. The increasing adoption of digital health solutions integrated with diabetes management devices further fuels market expansion. However, factors like high cost of advanced devices, especially CGMs and insulin pumps, coupled with potential reimbursement challenges across various European countries, may act as restraints. Germany, France, the UK, and Italy represent the largest national markets within Europe, contributing significantly to the overall market size due to their substantial diabetic populations and established healthcare infrastructure. Competitive landscape analysis reveals key players such as Roche Diabetes Care, Abbott Diabetes Care, Medtronic, and Dexcom, engaged in innovation and strategic partnerships to gain market share.
The forecast period (2025-2033) anticipates sustained growth driven by several factors. Continued advancements in device technology, including miniaturization, improved accuracy, and integrated data management capabilities, will be critical. Furthermore, increasing government initiatives promoting diabetes prevention and management programs, coupled with growing public-private partnerships, will play a significant role in driving market expansion. The market will likely see increased competition, with both established players and emerging companies focusing on innovation and affordability to cater to the expanding patient population. Regional variations in healthcare policies and reimbursement models will influence market growth trajectories across different European countries. Therefore, a comprehensive understanding of these factors is crucial for stakeholders seeking strategic positioning in the dynamic European diabetic care devices market.
Europe Diabetic Care Devices Market Report: 2019-2033
This comprehensive report provides a detailed analysis of the Europe Diabetic Care Devices Market, offering invaluable insights for stakeholders, investors, and industry professionals. Covering the period 2019-2033, with a base year of 2025 and a forecast period of 2025-2033, this report unravels market dynamics, competitive landscapes, and future growth prospects. The market size is estimated at XX Million in 2025 and is projected to reach XX Million by 2033, exhibiting a CAGR of XX%.
Europe Diabetic Care Devices Market Market Dynamics & Concentration
The European Diabetic Care Devices market is characterized by a moderately concentrated landscape, with several multinational corporations holding significant market share. The market is driven by factors such as the rising prevalence of diabetes, technological advancements in monitoring and management devices, and supportive regulatory frameworks. However, the market also faces challenges from the high cost of treatment, reimbursement policies, and the emergence of substitute therapies.
Market Concentration: The top 7 companies account for approximately XX% of the market share in 2025. Mergers and acquisitions (M&A) activity has been relatively moderate in recent years, with approximately XX deals recorded between 2019 and 2024.
Innovation Drivers: Continuous glucose monitoring (CGM) technology and the development of more user-friendly insulin delivery systems are major innovation drivers. Furthermore, integration of smart technologies and data analytics is improving disease management.
Regulatory Frameworks: The regulatory environment in Europe influences the market access and pricing of diabetic care devices. Stringent regulatory approvals impact innovation, but ensure product safety and efficacy.
Product Substitutes: While no direct substitutes exist, alternative treatment approaches, such as lifestyle modifications, impact market growth.
End-User Trends: Growing awareness of diabetes management and the rising demand for convenient and technologically advanced devices are shaping market trends.
M&A Activities: The M&A landscape has shown consistent activity with a focus on expanding product portfolios and gaining access to new technologies.
Europe Diabetic Care Devices Market Industry Trends & Analysis
The European Diabetic Care Devices market is experiencing robust growth, driven primarily by the increasing prevalence of diabetes across various age groups. Technological advancements such as the introduction of CGM systems and sophisticated insulin pumps have significantly enhanced diabetes management, contributing to market expansion.
Consumer preferences are shifting towards convenient, discreet, and connected devices, pushing manufacturers to innovate in areas such as wearable technology and mobile app integration. The competitive landscape is characterized by intense rivalry, with companies focusing on product differentiation, strategic partnerships, and technological advancements to gain a market edge. The market penetration of CGM devices is expected to increase significantly in the forecast period, driven by increased affordability and improved accuracy.
Leading Markets & Segments in Europe Diabetic Care Devices Market
The German and UK markets represent the largest segments within Europe, driven by factors such as high diabetes prevalence, well-established healthcare infrastructure, and favorable reimbursement policies. Self-monitoring blood glucose (SMBG) devices constitute the largest segment in terms of revenue, followed by insulin delivery systems.
Key Drivers in Germany & UK:
- High prevalence of type 1 & type 2 diabetes
- Robust healthcare infrastructure and insurance coverage
- Strong government initiatives to support diabetes management
- High levels of diabetes awareness and patient education
Dominant Segments:
- Self-monitoring Blood Glucose Devices (SMBG): Driven by ease of use, affordability, and widespread availability.
- Insulin Delivery Systems (Insulin Pumps, Pens): Growing demand due to improved glycemic control and patient convenience.
- Continuous Glucose Monitoring (CGM) Devices: Rapidly expanding segment driven by technological advancements and improved accuracy.
Europe Diabetic Care Devices Market Product Developments
Recent years have witnessed significant advancements in diabetic care devices, notably in continuous glucose monitoring (CGM) technology. The introduction of smaller, more accurate, and user-friendly CGMs is transforming diabetes management. Real-time data integration with mobile apps and cloud platforms offers personalized insights, enabling proactive interventions. Insulin delivery systems have also seen improvements, with the advent of smaller, smarter, and more discreet insulin pumps and pens. This focus on improved usability, convenience, and data integration drives market growth.
Key Drivers of Europe Diabetic Care Devices Market Growth
The growth of the European Diabetic Care Devices market is fueled by several key factors:
- Rising prevalence of diabetes: The increasing incidence of type 1 and type 2 diabetes across Europe is a primary growth driver.
- Technological advancements: The development of advanced CGM and insulin delivery systems improves diabetes management and patient quality of life.
- Favorable regulatory environment: Supportive government policies and reimbursement schemes facilitate market penetration of innovative devices.
Challenges in the Europe Diabetic Care Devices Market Market
The market faces challenges including:
- High cost of devices and consumables: The high price of CGM and insulin therapy restricts access for many patients.
- Reimbursement complexities: Variable reimbursement policies across European countries create market access hurdles.
- Competition: The intense competition among established players and emerging companies can impact profitability.
Emerging Opportunities in Europe Diabetic Care Devices Market
The market offers numerous opportunities for growth. Advancements in artificial intelligence (AI) and machine learning (ML) offer potential for more personalized diabetes management solutions. Strategic collaborations between device manufacturers and healthcare providers could streamline access and enhance patient care. Expansion into underserved markets and the development of affordable devices for low-income populations present further opportunities.
Leading Players in the Europe Diabetic Care Devices Market Sector
- Rossmax
- Agamatrix Inc
- Roche Diabetes Care
- Bionime Corporation
- Sanofi
- Eli Lilly
- Novo Nordisk A/S
- Abbott Diabetes Care
- LifeScan
- Medtronic
- Dexcom Inc
- Ascensia Diabetes Care
- Insulet Corporation
Key Milestones in Europe Diabetic Care Devices Market Industry
- February 2024: Dexcom launched the Dexcom ONE+ real-time CGM solution in Europe, offering a customizable and user-friendly device. This launch significantly expanded the availability of advanced CGM technology in the region.
- June 2022: Cequr launched the Insulin Pen 2.0TM, a wearable insulin delivery device with an integrated blood glucose meter. This innovation enhanced convenience and self-management capabilities for users.
Strategic Outlook for Europe Diabetic Care Devices Market Market
The European Diabetic Care Devices market holds significant potential for growth. The integration of digital health technologies, expansion of CGM utilization, and the development of more personalized treatment approaches will shape the market's future. Strategic partnerships, technological innovation, and a focus on improving patient access will be crucial for success. The market's long-term outlook is positive, driven by the increasing prevalence of diabetes, technological advancements, and favorable regulatory policies.
Europe Diabetic Care Devices Market Segmentation
-
1. Monitoring Devices
-
1.1. Self-monitoring Blood Glucose Devices
- 1.1.1. Glucometer Devices
- 1.1.2. Blood Glucose Test Strips
- 1.1.3. Lancets
-
1.2. Continuous Glucose Monitoring Devices
- 1.2.1. Sensors
- 1.2.2. Durables (Receivers and Transmitters)
-
1.1. Self-monitoring Blood Glucose Devices
-
2. Management Devices
-
2.1. Insulin Pump
- 2.1.1. Insulin Pump Device
- 2.1.2. Insulin Pump Reservoir
- 2.1.3. Infusion Set
- 2.2. Insulin Syringes
- 2.3. Cartridges in Reusable Pens
- 2.4. Insulin Disposable Pens
- 2.5. Jet Injectors
-
2.1. Insulin Pump
Europe Diabetic Care Devices Market Segmentation By Geography
- 1. France
- 2. Germany
- 3. Italy
- 4. Spain
- 5. United Kingdom
- 6. Russia
- 7. Rest of Europe
Europe Diabetic Care Devices Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2019-2033 |
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2025-2033 |
| Historical Period | 2019-2024 |
| Growth Rate | CAGR of 6.18% from 2019-2033 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increasing Demand for Better Dentistry and Better Aesthetic outcomes; Increase in the Disposable Income
- 3.3. Market Restrains
- 3.3.1. High Cost Associated with the Digital Dentistry
- 3.4. Market Trends
- 3.4.1. The continuous glucose monitoring segment is expected to witness the highest growth rate over the forecast period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 5.1.1. Self-monitoring Blood Glucose Devices
- 5.1.1.1. Glucometer Devices
- 5.1.1.2. Blood Glucose Test Strips
- 5.1.1.3. Lancets
- 5.1.2. Continuous Glucose Monitoring Devices
- 5.1.2.1. Sensors
- 5.1.2.2. Durables (Receivers and Transmitters)
- 5.1.1. Self-monitoring Blood Glucose Devices
- 5.2. Market Analysis, Insights and Forecast - by Management Devices
- 5.2.1. Insulin Pump
- 5.2.1.1. Insulin Pump Device
- 5.2.1.2. Insulin Pump Reservoir
- 5.2.1.3. Infusion Set
- 5.2.2. Insulin Syringes
- 5.2.3. Cartridges in Reusable Pens
- 5.2.4. Insulin Disposable Pens
- 5.2.5. Jet Injectors
- 5.2.1. Insulin Pump
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. France
- 5.3.2. Germany
- 5.3.3. Italy
- 5.3.4. Spain
- 5.3.5. United Kingdom
- 5.3.6. Russia
- 5.3.7. Rest of Europe
- 5.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 6. France Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 6.1.1. Self-monitoring Blood Glucose Devices
- 6.1.1.1. Glucometer Devices
- 6.1.1.2. Blood Glucose Test Strips
- 6.1.1.3. Lancets
- 6.1.2. Continuous Glucose Monitoring Devices
- 6.1.2.1. Sensors
- 6.1.2.2. Durables (Receivers and Transmitters)
- 6.1.1. Self-monitoring Blood Glucose Devices
- 6.2. Market Analysis, Insights and Forecast - by Management Devices
- 6.2.1. Insulin Pump
- 6.2.1.1. Insulin Pump Device
- 6.2.1.2. Insulin Pump Reservoir
- 6.2.1.3. Infusion Set
- 6.2.2. Insulin Syringes
- 6.2.3. Cartridges in Reusable Pens
- 6.2.4. Insulin Disposable Pens
- 6.2.5. Jet Injectors
- 6.2.1. Insulin Pump
- 6.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 7. Germany Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 7.1.1. Self-monitoring Blood Glucose Devices
- 7.1.1.1. Glucometer Devices
- 7.1.1.2. Blood Glucose Test Strips
- 7.1.1.3. Lancets
- 7.1.2. Continuous Glucose Monitoring Devices
- 7.1.2.1. Sensors
- 7.1.2.2. Durables (Receivers and Transmitters)
- 7.1.1. Self-monitoring Blood Glucose Devices
- 7.2. Market Analysis, Insights and Forecast - by Management Devices
- 7.2.1. Insulin Pump
- 7.2.1.1. Insulin Pump Device
- 7.2.1.2. Insulin Pump Reservoir
- 7.2.1.3. Infusion Set
- 7.2.2. Insulin Syringes
- 7.2.3. Cartridges in Reusable Pens
- 7.2.4. Insulin Disposable Pens
- 7.2.5. Jet Injectors
- 7.2.1. Insulin Pump
- 7.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 8. Italy Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 8.1.1. Self-monitoring Blood Glucose Devices
- 8.1.1.1. Glucometer Devices
- 8.1.1.2. Blood Glucose Test Strips
- 8.1.1.3. Lancets
- 8.1.2. Continuous Glucose Monitoring Devices
- 8.1.2.1. Sensors
- 8.1.2.2. Durables (Receivers and Transmitters)
- 8.1.1. Self-monitoring Blood Glucose Devices
- 8.2. Market Analysis, Insights and Forecast - by Management Devices
- 8.2.1. Insulin Pump
- 8.2.1.1. Insulin Pump Device
- 8.2.1.2. Insulin Pump Reservoir
- 8.2.1.3. Infusion Set
- 8.2.2. Insulin Syringes
- 8.2.3. Cartridges in Reusable Pens
- 8.2.4. Insulin Disposable Pens
- 8.2.5. Jet Injectors
- 8.2.1. Insulin Pump
- 8.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 9. Spain Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 9.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 9.1.1. Self-monitoring Blood Glucose Devices
- 9.1.1.1. Glucometer Devices
- 9.1.1.2. Blood Glucose Test Strips
- 9.1.1.3. Lancets
- 9.1.2. Continuous Glucose Monitoring Devices
- 9.1.2.1. Sensors
- 9.1.2.2. Durables (Receivers and Transmitters)
- 9.1.1. Self-monitoring Blood Glucose Devices
- 9.2. Market Analysis, Insights and Forecast - by Management Devices
- 9.2.1. Insulin Pump
- 9.2.1.1. Insulin Pump Device
- 9.2.1.2. Insulin Pump Reservoir
- 9.2.1.3. Infusion Set
- 9.2.2. Insulin Syringes
- 9.2.3. Cartridges in Reusable Pens
- 9.2.4. Insulin Disposable Pens
- 9.2.5. Jet Injectors
- 9.2.1. Insulin Pump
- 9.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 10. United Kingdom Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 10.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 10.1.1. Self-monitoring Blood Glucose Devices
- 10.1.1.1. Glucometer Devices
- 10.1.1.2. Blood Glucose Test Strips
- 10.1.1.3. Lancets
- 10.1.2. Continuous Glucose Monitoring Devices
- 10.1.2.1. Sensors
- 10.1.2.2. Durables (Receivers and Transmitters)
- 10.1.1. Self-monitoring Blood Glucose Devices
- 10.2. Market Analysis, Insights and Forecast - by Management Devices
- 10.2.1. Insulin Pump
- 10.2.1.1. Insulin Pump Device
- 10.2.1.2. Insulin Pump Reservoir
- 10.2.1.3. Infusion Set
- 10.2.2. Insulin Syringes
- 10.2.3. Cartridges in Reusable Pens
- 10.2.4. Insulin Disposable Pens
- 10.2.5. Jet Injectors
- 10.2.1. Insulin Pump
- 10.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 11. Russia Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 11.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 11.1.1. Self-monitoring Blood Glucose Devices
- 11.1.1.1. Glucometer Devices
- 11.1.1.2. Blood Glucose Test Strips
- 11.1.1.3. Lancets
- 11.1.2. Continuous Glucose Monitoring Devices
- 11.1.2.1. Sensors
- 11.1.2.2. Durables (Receivers and Transmitters)
- 11.1.1. Self-monitoring Blood Glucose Devices
- 11.2. Market Analysis, Insights and Forecast - by Management Devices
- 11.2.1. Insulin Pump
- 11.2.1.1. Insulin Pump Device
- 11.2.1.2. Insulin Pump Reservoir
- 11.2.1.3. Infusion Set
- 11.2.2. Insulin Syringes
- 11.2.3. Cartridges in Reusable Pens
- 11.2.4. Insulin Disposable Pens
- 11.2.5. Jet Injectors
- 11.2.1. Insulin Pump
- 11.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 12. Rest of Europe Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 12.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 12.1.1. Self-monitoring Blood Glucose Devices
- 12.1.1.1. Glucometer Devices
- 12.1.1.2. Blood Glucose Test Strips
- 12.1.1.3. Lancets
- 12.1.2. Continuous Glucose Monitoring Devices
- 12.1.2.1. Sensors
- 12.1.2.2. Durables (Receivers and Transmitters)
- 12.1.1. Self-monitoring Blood Glucose Devices
- 12.2. Market Analysis, Insights and Forecast - by Management Devices
- 12.2.1. Insulin Pump
- 12.2.1.1. Insulin Pump Device
- 12.2.1.2. Insulin Pump Reservoir
- 12.2.1.3. Infusion Set
- 12.2.2. Insulin Syringes
- 12.2.3. Cartridges in Reusable Pens
- 12.2.4. Insulin Disposable Pens
- 12.2.5. Jet Injectors
- 12.2.1. Insulin Pump
- 12.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 13. Germany Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 14. France Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 15. Italy Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 16. United Kingdom Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 17. Netherlands Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 18. Sweden Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 19. Rest of Europe Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 20. Competitive Analysis
- 20.1. Market Share Analysis 2024
- 20.2. Company Profiles
- 20.2.1 Rossmax*List Not Exhaustive 7 2 COMPANY SHARE ANALYSIS
- 20.2.1.1. Overview
- 20.2.1.2. Products
- 20.2.1.3. SWOT Analysis
- 20.2.1.4. Recent Developments
- 20.2.1.5. Financials (Based on Availability)
- 20.2.2 Agamatrix Inc
- 20.2.2.1. Overview
- 20.2.2.2. Products
- 20.2.2.3. SWOT Analysis
- 20.2.2.4. Recent Developments
- 20.2.2.5. Financials (Based on Availability)
- 20.2.3 Self-monitoring Blood Glucose Devices
- 20.2.3.1. Overview
- 20.2.3.2. Products
- 20.2.3.3. SWOT Analysis
- 20.2.3.4. Recent Developments
- 20.2.3.5. Financials (Based on Availability)
- 20.2.4 Roche Diabetes Care
- 20.2.4.1. Overview
- 20.2.4.2. Products
- 20.2.4.3. SWOT Analysis
- 20.2.4.4. Recent Developments
- 20.2.4.5. Financials (Based on Availability)
- 20.2.5 Bionime Corporation
- 20.2.5.1. Overview
- 20.2.5.2. Products
- 20.2.5.3. SWOT Analysis
- 20.2.5.4. Recent Developments
- 20.2.5.5. Financials (Based on Availability)
- 20.2.6 Sanofi
- 20.2.6.1. Overview
- 20.2.6.2. Products
- 20.2.6.3. SWOT Analysis
- 20.2.6.4. Recent Developments
- 20.2.6.5. Financials (Based on Availability)
- 20.2.7 Eli Lilly
- 20.2.7.1. Overview
- 20.2.7.2. Products
- 20.2.7.3. SWOT Analysis
- 20.2.7.4. Recent Developments
- 20.2.7.5. Financials (Based on Availability)
- 20.2.8 Novo Nordisk A/S
- 20.2.8.1. Overview
- 20.2.8.2. Products
- 20.2.8.3. SWOT Analysis
- 20.2.8.4. Recent Developments
- 20.2.8.5. Financials (Based on Availability)
- 20.2.9 Abbott Diabetes Care
- 20.2.9.1. Overview
- 20.2.9.2. Products
- 20.2.9.3. SWOT Analysis
- 20.2.9.4. Recent Developments
- 20.2.9.5. Financials (Based on Availability)
- 20.2.10 LifeScan
- 20.2.10.1. Overview
- 20.2.10.2. Products
- 20.2.10.3. SWOT Analysis
- 20.2.10.4. Recent Developments
- 20.2.10.5. Financials (Based on Availability)
- 20.2.11 Medtronic
- 20.2.11.1. Overview
- 20.2.11.2. Products
- 20.2.11.3. SWOT Analysis
- 20.2.11.4. Recent Developments
- 20.2.11.5. Financials (Based on Availability)
- 20.2.12 7 COMPETITIVE LANDSCAPE7 1 COMPANY PROFILES
- 20.2.12.1. Overview
- 20.2.12.2. Products
- 20.2.12.3. SWOT Analysis
- 20.2.12.4. Recent Developments
- 20.2.12.5. Financials (Based on Availability)
- 20.2.13 Insulin Device
- 20.2.13.1. Overview
- 20.2.13.2. Products
- 20.2.13.3. SWOT Analysis
- 20.2.13.4. Recent Developments
- 20.2.13.5. Financials (Based on Availability)
- 20.2.14 Dexcom Inc
- 20.2.14.1. Overview
- 20.2.14.2. Products
- 20.2.14.3. SWOT Analysis
- 20.2.14.4. Recent Developments
- 20.2.14.5. Financials (Based on Availability)
- 20.2.15 Continuous Glucose Monitoring Devices
- 20.2.15.1. Overview
- 20.2.15.2. Products
- 20.2.15.3. SWOT Analysis
- 20.2.15.4. Recent Developments
- 20.2.15.5. Financials (Based on Availability)
- 20.2.16 Ascensia Diabetes Care
- 20.2.16.1. Overview
- 20.2.16.2. Products
- 20.2.16.3. SWOT Analysis
- 20.2.16.4. Recent Developments
- 20.2.16.5. Financials (Based on Availability)
- 20.2.17 Insulet Corporation
- 20.2.17.1. Overview
- 20.2.17.2. Products
- 20.2.17.3. SWOT Analysis
- 20.2.17.4. Recent Developments
- 20.2.17.5. Financials (Based on Availability)
- 20.2.1 Rossmax*List Not Exhaustive 7 2 COMPANY SHARE ANALYSIS
List of Figures
- Figure 1: Europe Diabetic Care Devices Market Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: Europe Diabetic Care Devices Market Share (%) by Company 2024
List of Tables
- Table 1: Europe Diabetic Care Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Europe Diabetic Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 3: Europe Diabetic Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 4: Europe Diabetic Care Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 5: Europe Diabetic Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 6: Germany Europe Diabetic Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 7: France Europe Diabetic Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 8: Italy Europe Diabetic Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 9: United Kingdom Europe Diabetic Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 10: Netherlands Europe Diabetic Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 11: Sweden Europe Diabetic Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 12: Rest of Europe Europe Diabetic Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 13: Europe Diabetic Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 14: Europe Diabetic Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 15: Europe Diabetic Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 16: Europe Diabetic Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 17: Europe Diabetic Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 18: Europe Diabetic Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 19: Europe Diabetic Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 20: Europe Diabetic Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 21: Europe Diabetic Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 22: Europe Diabetic Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 23: Europe Diabetic Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 24: Europe Diabetic Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 25: Europe Diabetic Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 26: Europe Diabetic Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 27: Europe Diabetic Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 28: Europe Diabetic Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 29: Europe Diabetic Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 30: Europe Diabetic Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 31: Europe Diabetic Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 32: Europe Diabetic Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 33: Europe Diabetic Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Europe Diabetic Care Devices Market?
The projected CAGR is approximately 6.18%.
2. Which companies are prominent players in the Europe Diabetic Care Devices Market?
Key companies in the market include Rossmax*List Not Exhaustive 7 2 COMPANY SHARE ANALYSIS, Agamatrix Inc, Self-monitoring Blood Glucose Devices, Roche Diabetes Care, Bionime Corporation, Sanofi, Eli Lilly, Novo Nordisk A/S, Abbott Diabetes Care, LifeScan, Medtronic, 7 COMPETITIVE LANDSCAPE7 1 COMPANY PROFILES, Insulin Device, Dexcom Inc, Continuous Glucose Monitoring Devices, Ascensia Diabetes Care, Insulet Corporation.
3. What are the main segments of the Europe Diabetic Care Devices Market?
The market segments include Monitoring Devices, Management Devices.
4. Can you provide details about the market size?
The market size is estimated to be USD 8.03 Million as of 2022.
5. What are some drivers contributing to market growth?
Increasing Demand for Better Dentistry and Better Aesthetic outcomes; Increase in the Disposable Income.
6. What are the notable trends driving market growth?
The continuous glucose monitoring segment is expected to witness the highest growth rate over the forecast period.
7. Are there any restraints impacting market growth?
High Cost Associated with the Digital Dentistry.
8. Can you provide examples of recent developments in the market?
Feburary 2024: Dexcom launched real-time CGM solution Dexcom ONE+ in Europe. Dexcom ONE+ is a customisable continuous glucose monitoring solution that can be worn at three different location on the body.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Europe Diabetic Care Devices Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Europe Diabetic Care Devices Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Europe Diabetic Care Devices Market?
To stay informed about further developments, trends, and reports in the Europe Diabetic Care Devices Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
